Skip to main content
. 2020 Oct 29;2020:7612126. doi: 10.1155/2020/7612126

Figure 4.

Figure 4

Sedimentation volumes (%) of metronidazole benzoate suspension formulations containing different concentrations of (a) GFM, (b) SCMC, and (c) XGM suspending agents, (n = 3, mean ± SD).